Skip to main content
SONVY logo

Sonova Holding AG (SONVY) Stock Price & Analysis

Sonova Holding AG (SONVY) — price $69.42 (+0.39%), as of the Nov 19, 2026 trading session; market cap $20.7B.

Educational signal · not a buy or sell recommendation · How to read this

$69.42 +$0.27 (+0.39%) Market Cap $20.7B

Sonova Holding AG · SONVY · Healthcare · Medical - Devices

Sonova Holding AG is a prominent developer, manufacturer, and global distributor of hearing health solutions for all age groups.

Price as of Nov 19, 2026

Key Statistics

No MoonshotScore yet: we have not published a score for this company.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • ZBH · Zimmer Biomet Holdings, Inc. · 79 /100
  • STE · STERIS plc · 87 /100
  • PHG · Koninklijke Philips N.V. · 78 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$69.42
Change on the day+0.39%
52-week range$42.26–$71.91
Market capitalisation$20.7B—
Price / earnings (trailing)34.69
Shares traded on the day711
Beta (volatility vs the S&P 500)1.09

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $43, high $70, latest $69. $70 $43 high $70 Oct 17, 2025 Nov 19, 2026 · $69 $55Oct 17, 2025$54Oct 31, 2025$51Nov 14, 2025$50Nov 28, 2025$50Dec 12, 2025$52Dec 26, 2025$53Jan 9, 2026$56Jan 23, 2026$53Feb 6, 2026$51Feb 20, 2026$49Mar 6, 2026$45Mar 20, 2026$45Apr 2, 2026$49Apr 17, 2026$44May 1, 2026$45May 15, 2026$53May 29, 2026$50Jun 12, 2026$48Jun 26, 2026$50Jul 10, 2026$52Jul 24, 2026$58Aug 7, 2026$61Aug 21, 2026$58Sep 4, 2026$56Sep 18, 2026$60Oct 2, 2026$67Oct 16, 2026$69Oct 30, 2026$68Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Sonova Holding AG (SONVY): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Neutral
Revenue Growth Negative
Debt/Equity Weak
ROE Strong
Gross Margin Strong

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 11, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Sonova Holding AG (SONVY), and what does it report?

Short answer

Sonova Holding AG is a prominent developer, manufacturer, and global distributor of hearing health solutions for all age groups. Healthcare / Medical Devices Headquarters: Laubisrutistrasse 28, Stäfa, ZH, 8712, CH. It employs 18,447 people and is led by Eric Alain Bernard. In Q2 FY2027 it reported revenue of CHF 1.84B and net income of CHF 252M. The market values it at $20.7B.

2 · Latest results

What do the latest results show for Sonova Holding AG (SONVY)?

Short answer · as of

The most recent reported quarter, Q2 FY2027, carried revenue of CHF 1.84B. Against analyst estimates the company has EPS beat 4 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2027CHF 1.84BCHF 252MCHF 0.84 (diluted)
Q4 FY2026CHF 1.79BCHF 243MCHF 0.82 (diluted)
Q2 FY2026CHF 1.78BCHF 185MCHF 0.62 (diluted)
Q4 FY2025CHF 2.03BCHF 332MCHF 1.11 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Sonova Holding AG (SONVY)?

Short answer · as of

The distress and quality screens read Altman Z 5.41 · Piotroski F 8. Trailing ratios: ROE 18.3% · ROA 8.3% · current ratio 1.69 · earnings yield 2.9% · free-cash-flow yield 4.0%.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held SONVY in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported SONVY in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What Investors Ask About Sonova Holding AG (SONVY) — Healthcare

Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.

What does Phonak contribute to Sonova?

Phonak is a core hearing-instrument brand within Sonova’s portfolio. Its products are distributed alongside other hearing brands through independent partners and the wider hearing-care ecosystem.

Why does Advanced Bionics matter to Sonova’s outlook?

Advanced Bionics carries Sonova’s cochlear implant offering. Management has linked expected performance improvement to a planned new sound processor, making product execution in this business especially important.

How does Sennheiser change Sonova’s business mix?

Sennheiser adds consumer headphones, hearables, microphones, and wireless transmission products to a group otherwise centered on hearing care and implants. Sonova is therefore exposed to consumer-audio demand as well as clinical hearing needs.

Why does institutional ownership look sparse for SONVY?

The reported filing-based ownership record contains a limited holder set, with Rhumbline Advisers the largest disclosed holder. The listing is on the over-the-counter market, so this record should be read as the reported footprint for SONVY rather than a complete map of Sonova’s global shareholder base.

What is the SONVY stock price today?

The last price recorded for Sonova Holding AG (SONVY), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 19 figures on this page — 15 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • FAQ: What does Phonak contribute to Sonova?: Business description
  • FAQ: Why does Advanced Bionics matter to Sonova’s outlook?: Business description; Management outlook — dated call excerpts
  • FAQ: How does Sennheiser change Sonova’s business mix?: Business description
  • FAQ: Why does institutional ownership look sparse for SONVY?: Ticker / exchange; Institutional ownership (13F); Largest 5 institutional holders
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.